clinical trial · NCT05365425
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Seoul National University Bundang Hospital·phase4·recruiting·n = 56
DyslipidemiaAtherosclerosisDiabetes Mellitus, Type 2Choline fenofibratePolicosanol
brief summary
This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.
started
Jun 1, 2023
primary completion
Dec 31, 2025
completion
Dec 31, 2026
last updated
May 1, 2024
detailed description
In patients with type 2 diabetes with atherosclerotic combined dyslipidemia, the effect of choline fenofibrate on the progression of carotid intima media thickness and carotid artery plaque will be evaluated by 3D carotid ultrasound.
official title
Effect of Choline Fenofibrate on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes and Combined Dyslipidemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol